BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32652215)

  • 1. Economic analysis of healthcare-associated infection prevention and control interventions in medical and surgical units: systematic review using a discounting approach.
    Tchouaket Nguemeleu E; Beogo I; Sia D; Kilpatrick K; Séguin C; Baillot A; Jabbour M; Parisien N; Robins S; Boivin S
    J Hosp Infect; 2020 Sep; 106(1):134-154. PubMed ID: 32652215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for a systematic review of economic analyses of nosocomial infection prevention and control interventions in OECD hospitals.
    Tchouaket EN; Beogo I; Sia D; Kilpatrick K; Séguin C; Baillot A; Nadar M; Parisien N; Boivin S
    BMJ Open; 2020 Jul; 10(7):e037765. PubMed ID: 32665392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pre-pandemic COVID-19 assessment of the costs of prevention and control interventions for healthcare associated infections in medical and surgical wards in Québec.
    Tchouaket Nguemeleu E; Robins S; Boivin S; Sia D; Kilpatrick K; Dubreuil B; Larouche C; Parisien N; Letourneau J
    Antimicrob Resist Infect Control; 2021 Oct; 10(1):150. PubMed ID: 34674758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of healthcare-associated infection prevention and control in long-term care: a systematic review protocol.
    Tchouaket EN; Kruglova K; Beogo I; Sia D; Robins S; Bélanger E; Jubinville M; Séguin C; Kilpatrick K; Boivin S; Létourneau J
    Syst Rev; 2022 Dec; 11(1):261. PubMed ID: 36463274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economics of infection prevention: why it is crucial to invest in hand hygiene and nurses during the novel coronavirus pandemic.
    Peters A; Lotfinejad N; Simniceanu A; Pittet D
    J Infect; 2020 Aug; 81(2):318-356. PubMed ID: 32335177
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention is life- and cost-saving.
    Baussano I; Sankaranarayanan R; Weiderpass E
    Prev Med; 2020 Sep; 138():106150. PubMed ID: 32473263
    [No Abstract]   [Full Text] [Related]  

  • 7. Economic evaluation of vancomycin-resistant enterococci (VRE) control practices: a systematic review.
    MacDougall C; Johnstone J; Prematunge C; Adomako K; Nadolny E; Truong E; Saedi A; Garber G; Sander B
    J Hosp Infect; 2020 May; 105(1):53-63. PubMed ID: 31857122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What are the economic implications of COVID-19.
    Zouari A
    Tunis Med; 2020 Apr; 98(4):312-313. PubMed ID: 32395795
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of surgical lung cancer patients during the COVID-19 pandemic in the financially and resource strained Greek health care system.
    Kapetanakis EI; Tomos IP; Karakatsani A; Koumarianou A; Tomos PI
    J Surg Oncol; 2020 Aug; 122(2):124-127. PubMed ID: 32446272
    [No Abstract]   [Full Text] [Related]  

  • 10. Notes on cost benefit of COVID-19 lockdown.
    Mills M; Allen MB
    J Appl Clin Med Phys; 2020 Jul; 21(7):4-6. PubMed ID: 32619322
    [No Abstract]   [Full Text] [Related]  

  • 11. Active testing of groups at increased risk of acquiring SARS-CoV-2 in Canada: costs and human resource needs.
    Campbell JR; Uppal A; Oxlade O; Fregonese F; Bastos ML; Lan Z; Law S; Oh CE; Russell WA; Sulis G; Winters N; Yanes-Lane M; Brisson M; Laszlo S; Evans TG; Menzies D
    CMAJ; 2020 Oct; 192(40):E1146-E1155. PubMed ID: 32907820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staggered release policies for COVID-19 control: Costs and benefits of relaxing restrictions by age and risk.
    Zhao H; Feng Z
    Math Biosci; 2020 Aug; 326():108405. PubMed ID: 32565231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Financial Impact of COVID-19 on Our Practice.
    Ferneini EM
    J Oral Maxillofac Surg; 2020 Jul; 78(7):1047-1048. PubMed ID: 32302531
    [No Abstract]   [Full Text] [Related]  

  • 14. Covid-19, unemployment, and health: time for deeper solutions?
    Hensher M
    BMJ; 2020 Oct; 371():m3687. PubMed ID: 33032997
    [No Abstract]   [Full Text] [Related]  

  • 15. Reducing hand recontamination of healthcare workers during COVID-19.
    Gon G; Dancer S; Dreibelbis R; Graham WJ; Kilpatrick C
    Infect Control Hosp Epidemiol; 2020 Jul; 41(7):870-871. PubMed ID: 32248864
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19-a very visible pandemic.
    Durrheim DN; Baker MG
    Lancet; 2020 Aug; 396(10248):e17. PubMed ID: 32771112
    [No Abstract]   [Full Text] [Related]  

  • 17. Economic implications of the COVID-19 pandemic on the plastic surgery community.
    Inglesby DC; Boyd CJ
    J Plast Reconstr Aesthet Surg; 2020 Jul; 73(7):1357-1404. PubMed ID: 32471766
    [No Abstract]   [Full Text] [Related]  

  • 18. Health Equity During COVID-19.
    Vanjani R; Martino S; Wunsch C
    J Gen Intern Med; 2020 Oct; 35(10):3067-3068. PubMed ID: 32705470
    [No Abstract]   [Full Text] [Related]  

  • 19. Leadership in the Aftermath of Coronavirus Disease 2019 (COVID-19): Next Steps Post Surge.
    Lexa FJ; Fessell D
    J Am Coll Radiol; 2020 Jul; 17(7):913-914. PubMed ID: 32492368
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19: implementing sustainable low cost physical distancing and enhanced hygiene.
    Dalton CB; Corbett SJ; Katelaris AL
    Med J Aust; 2020 Jun; 212(10):443-446.e1. PubMed ID: 32356573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.